Quick jump to page content
Main Navigation
Main Content
Sidebar
Register
Login
Toggle navigation
Home
About
About the Journal
Submissions
Editorial Team
Privacy Statement
Contact
Current
Archives
Submission
Search
, Northwestern University Feinberg School of Medicine, Chicago, IL
SKIN The Journal of Cutaneous Medicine Vol. 7 No. 3 (2023): May Issue and Posters from WCH23 & WCM23
- Atopic Dermatitis
Early Insights into the Characteristics of Tralokinumab Patients in a Real-World Setting in the United States
Abstract
Poster PDF
SKIN The Journal of Cutaneous Medicine Vol. 3 (2019): Supplemental Issue: Scientific Posters Presented at 2019 Fall Clinical Dermatology Conference®-Las Vegas
- Eczema & Xerosis
Lebrikizumab, a High-Affinity IL-13 Inhibitor, Improves Clinical Manifestations in Moderate-to-Severe Atopic Dermatitis: Primary Results From a Randomized, Double-Blinded, Placebo-Controlled, Dose-Ranging, Phase 2b Study
Abstract
Poster PDF
×
Modal Header